nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Paget's disease of bone—ankylosing spondylitis	0.485	0.522	CtDrD
Pamidronate—osteoporosis—ankylosing spondylitis	0.444	0.478	CtDrD
Pamidronate—Discomfort—Triamcinolone—ankylosing spondylitis	0.000108	0.00152	CcSEcCtD
Pamidronate—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000108	0.00151	CcSEcCtD
Pamidronate—Renal failure—Methotrexate—ankylosing spondylitis	0.000107	0.0015	CcSEcCtD
Pamidronate—Angioedema—Betamethasone—ankylosing spondylitis	0.000107	0.00149	CcSEcCtD
Pamidronate—Angioedema—Dexamethasone—ankylosing spondylitis	0.000107	0.00149	CcSEcCtD
Pamidronate—Stomatitis—Methotrexate—ankylosing spondylitis	0.000106	0.00148	CcSEcCtD
Pamidronate—Angiopathy—Prednisone—ankylosing spondylitis	0.000106	0.00148	CcSEcCtD
Pamidronate—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000106	0.00148	CcSEcCtD
Pamidronate—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000106	0.00148	CcSEcCtD
Pamidronate—Immune system disorder—Prednisone—ankylosing spondylitis	0.000106	0.00148	CcSEcCtD
Pamidronate—Malaise—Dexamethasone—ankylosing spondylitis	0.000105	0.00148	CcSEcCtD
Pamidronate—Malaise—Betamethasone—ankylosing spondylitis	0.000105	0.00148	CcSEcCtD
Pamidronate—Oedema—Triamcinolone—ankylosing spondylitis	0.000105	0.00147	CcSEcCtD
Pamidronate—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000105	0.00147	CcSEcCtD
Pamidronate—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000105	0.00147	CcSEcCtD
Pamidronate—Syncope—Betamethasone—ankylosing spondylitis	0.000105	0.00147	CcSEcCtD
Pamidronate—Syncope—Dexamethasone—ankylosing spondylitis	0.000105	0.00147	CcSEcCtD
Pamidronate—Infection—Triamcinolone—ankylosing spondylitis	0.000104	0.00146	CcSEcCtD
Pamidronate—Infection—Methylprednisolone—ankylosing spondylitis	0.000104	0.00146	CcSEcCtD
Pamidronate—Haematuria—Methotrexate—ankylosing spondylitis	0.000104	0.00145	CcSEcCtD
Pamidronate—Shock—Triamcinolone—ankylosing spondylitis	0.000103	0.00145	CcSEcCtD
Pamidronate—Insomnia—Prednisolone—ankylosing spondylitis	0.000103	0.00145	CcSEcCtD
Pamidronate—Alopecia—Prednisone—ankylosing spondylitis	0.000103	0.00145	CcSEcCtD
Pamidronate—Shock—Methylprednisolone—ankylosing spondylitis	0.000103	0.00144	CcSEcCtD
Pamidronate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000103	0.00144	CcSEcCtD
Pamidronate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000103	0.00144	CcSEcCtD
Pamidronate—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000103	0.00144	CcSEcCtD
Pamidronate—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000103	0.00144	CcSEcCtD
Pamidronate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000103	0.00144	CcSEcCtD
Pamidronate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000102	0.00143	CcSEcCtD
Pamidronate—Erythema—Prednisone—ankylosing spondylitis	0.000102	0.00142	CcSEcCtD
Pamidronate—Malnutrition—Prednisone—ankylosing spondylitis	0.000102	0.00142	CcSEcCtD
Pamidronate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000102	0.00142	CcSEcCtD
Pamidronate—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000102	0.00142	CcSEcCtD
Pamidronate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000101	0.00142	CcSEcCtD
Pamidronate—Convulsion—Dexamethasone—ankylosing spondylitis	0.000101	0.00142	CcSEcCtD
Pamidronate—Convulsion—Betamethasone—ankylosing spondylitis	0.000101	0.00142	CcSEcCtD
Pamidronate—Hypertension—Betamethasone—ankylosing spondylitis	0.000101	0.00141	CcSEcCtD
Pamidronate—Hypertension—Dexamethasone—ankylosing spondylitis	0.000101	0.00141	CcSEcCtD
Pamidronate—Myalgia—Betamethasone—ankylosing spondylitis	9.96e-05	0.00139	CcSEcCtD
Pamidronate—Myalgia—Dexamethasone—ankylosing spondylitis	9.96e-05	0.00139	CcSEcCtD
Pamidronate—Anxiety—Betamethasone—ankylosing spondylitis	9.92e-05	0.00139	CcSEcCtD
Pamidronate—Anxiety—Dexamethasone—ankylosing spondylitis	9.92e-05	0.00139	CcSEcCtD
Pamidronate—Discomfort—Betamethasone—ankylosing spondylitis	9.84e-05	0.00138	CcSEcCtD
Pamidronate—Discomfort—Dexamethasone—ankylosing spondylitis	9.84e-05	0.00138	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—ankylosing spondylitis	9.83e-05	0.00137	CcSEcCtD
Pamidronate—Hypotension—Methylprednisolone—ankylosing spondylitis	9.81e-05	0.00137	CcSEcCtD
Pamidronate—Pain—Prednisolone—ankylosing spondylitis	9.78e-05	0.00137	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—ankylosing spondylitis	9.78e-05	0.00137	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—ankylosing spondylitis	9.66e-05	0.00135	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—ankylosing spondylitis	9.58e-05	0.00134	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	9.58e-05	0.00134	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	9.56e-05	0.00134	CcSEcCtD
Pamidronate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	9.54e-05	0.00134	CcSEcCtD
Pamidronate—Oedema—Dexamethasone—ankylosing spondylitis	9.54e-05	0.00134	CcSEcCtD
Pamidronate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	9.54e-05	0.00134	CcSEcCtD
Pamidronate—Oedema—Betamethasone—ankylosing spondylitis	9.54e-05	0.00134	CcSEcCtD
Pamidronate—Insomnia—Triamcinolone—ankylosing spondylitis	9.51e-05	0.00133	CcSEcCtD
Pamidronate—Insomnia—Methylprednisolone—ankylosing spondylitis	9.49e-05	0.00133	CcSEcCtD
Pamidronate—Infection—Dexamethasone—ankylosing spondylitis	9.48e-05	0.00133	CcSEcCtD
Pamidronate—Infection—Betamethasone—ankylosing spondylitis	9.48e-05	0.00133	CcSEcCtD
Pamidronate—Ill-defined disorder—Prednisone—ankylosing spondylitis	9.45e-05	0.00132	CcSEcCtD
Pamidronate—Paraesthesia—Triamcinolone—ankylosing spondylitis	9.44e-05	0.00132	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisolone—ankylosing spondylitis	9.43e-05	0.00132	CcSEcCtD
Pamidronate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	9.42e-05	0.00132	CcSEcCtD
Pamidronate—Anaemia—Prednisone—ankylosing spondylitis	9.41e-05	0.00132	CcSEcCtD
Pamidronate—Shock—Dexamethasone—ankylosing spondylitis	9.39e-05	0.00131	CcSEcCtD
Pamidronate—Shock—Betamethasone—ankylosing spondylitis	9.39e-05	0.00131	CcSEcCtD
Pamidronate—Dyspnoea—Triamcinolone—ankylosing spondylitis	9.38e-05	0.00131	CcSEcCtD
Pamidronate—Nervous system disorder—Betamethasone—ankylosing spondylitis	9.36e-05	0.00131	CcSEcCtD
Pamidronate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	9.36e-05	0.00131	CcSEcCtD
Pamidronate—Agitation—Prednisone—ankylosing spondylitis	9.36e-05	0.00131	CcSEcCtD
Pamidronate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	9.34e-05	0.00131	CcSEcCtD
Pamidronate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	9.34e-05	0.00131	CcSEcCtD
Pamidronate—Tachycardia—Betamethasone—ankylosing spondylitis	9.31e-05	0.0013	CcSEcCtD
Pamidronate—Tachycardia—Dexamethasone—ankylosing spondylitis	9.31e-05	0.0013	CcSEcCtD
Pamidronate—Angioedema—Prednisone—ankylosing spondylitis	9.31e-05	0.0013	CcSEcCtD
Pamidronate—Dyspepsia—Triamcinolone—ankylosing spondylitis	9.26e-05	0.0013	CcSEcCtD
Pamidronate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	9.24e-05	0.00129	CcSEcCtD
Pamidronate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	9.23e-05	0.00129	CcSEcCtD
Pamidronate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	9.23e-05	0.00129	CcSEcCtD
Pamidronate—Malaise—Prednisone—ankylosing spondylitis	9.18e-05	0.00128	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—ankylosing spondylitis	9.14e-05	0.00128	CcSEcCtD
Pamidronate—Syncope—Prednisone—ankylosing spondylitis	9.13e-05	0.00128	CcSEcCtD
Pamidronate—Anorexia—Betamethasone—ankylosing spondylitis	9.1e-05	0.00127	CcSEcCtD
Pamidronate—Anorexia—Dexamethasone—ankylosing spondylitis	9.1e-05	0.00127	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—ankylosing spondylitis	9.07e-05	0.00127	CcSEcCtD
Pamidronate—Fatigue—Triamcinolone—ankylosing spondylitis	9.07e-05	0.00127	CcSEcCtD
Pamidronate—Fatigue—Methylprednisolone—ankylosing spondylitis	9.05e-05	0.00127	CcSEcCtD
Pamidronate—Pain—Triamcinolone—ankylosing spondylitis	8.99e-05	0.00126	CcSEcCtD
Pamidronate—Loss of consciousness—Prednisone—ankylosing spondylitis	8.95e-05	0.00125	CcSEcCtD
Pamidronate—Hypotension—Dexamethasone—ankylosing spondylitis	8.92e-05	0.00125	CcSEcCtD
Pamidronate—Hypotension—Betamethasone—ankylosing spondylitis	8.92e-05	0.00125	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—ankylosing spondylitis	8.87e-05	0.00124	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—ankylosing spondylitis	8.83e-05	0.00124	CcSEcCtD
Pamidronate—Convulsion—Prednisone—ankylosing spondylitis	8.82e-05	0.00123	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	8.81e-05	0.00123	CcSEcCtD
Pamidronate—Hypertension—Prednisone—ankylosing spondylitis	8.79e-05	0.00123	CcSEcCtD
Pamidronate—Chills—Methotrexate—ankylosing spondylitis	8.77e-05	0.00123	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	8.7e-05	0.00122	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	8.7e-05	0.00122	CcSEcCtD
Pamidronate—Arthralgia—Prednisone—ankylosing spondylitis	8.67e-05	0.00121	CcSEcCtD
Pamidronate—Myalgia—Prednisone—ankylosing spondylitis	8.67e-05	0.00121	CcSEcCtD
Pamidronate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	8.67e-05	0.00121	CcSEcCtD
Pamidronate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	8.65e-05	0.00121	CcSEcCtD
Pamidronate—Anxiety—Prednisone—ankylosing spondylitis	8.64e-05	0.00121	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—ankylosing spondylitis	8.64e-05	0.00121	CcSEcCtD
Pamidronate—Insomnia—Betamethasone—ankylosing spondylitis	8.63e-05	0.00121	CcSEcCtD
Pamidronate—Insomnia—Dexamethasone—ankylosing spondylitis	8.63e-05	0.00121	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	8.58e-05	0.0012	CcSEcCtD
Pamidronate—Paraesthesia—Dexamethasone—ankylosing spondylitis	8.57e-05	0.0012	CcSEcCtD
Pamidronate—Paraesthesia—Betamethasone—ankylosing spondylitis	8.57e-05	0.0012	CcSEcCtD
Pamidronate—Discomfort—Prednisone—ankylosing spondylitis	8.57e-05	0.0012	CcSEcCtD
Pamidronate—Erythema—Methotrexate—ankylosing spondylitis	8.51e-05	0.00119	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—ankylosing spondylitis	8.51e-05	0.00119	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisolone—ankylosing spondylitis	8.43e-05	0.00118	CcSEcCtD
Pamidronate—Dyspepsia—Dexamethasone—ankylosing spondylitis	8.4e-05	0.00118	CcSEcCtD
Pamidronate—Dyspepsia—Betamethasone—ankylosing spondylitis	8.4e-05	0.00118	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—ankylosing spondylitis	8.33e-05	0.00117	CcSEcCtD
Pamidronate—Body temperature increased—Triamcinolone—ankylosing spondylitis	8.31e-05	0.00116	CcSEcCtD
Pamidronate—Oedema—Prednisone—ankylosing spondylitis	8.31e-05	0.00116	CcSEcCtD
Pamidronate—Anaphylactic shock—Prednisone—ankylosing spondylitis	8.31e-05	0.00116	CcSEcCtD
Pamidronate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	8.3e-05	0.00116	CcSEcCtD
Pamidronate—Decreased appetite—Dexamethasone—ankylosing spondylitis	8.3e-05	0.00116	CcSEcCtD
Pamidronate—Decreased appetite—Betamethasone—ankylosing spondylitis	8.3e-05	0.00116	CcSEcCtD
Pamidronate—Infection—Prednisone—ankylosing spondylitis	8.26e-05	0.00116	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	8.24e-05	0.00115	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	8.24e-05	0.00115	CcSEcCtD
Pamidronate—Back pain—Methotrexate—ankylosing spondylitis	8.23e-05	0.00115	CcSEcCtD
Pamidronate—Fatigue—Dexamethasone—ankylosing spondylitis	8.23e-05	0.00115	CcSEcCtD
Pamidronate—Fatigue—Betamethasone—ankylosing spondylitis	8.23e-05	0.00115	CcSEcCtD
Pamidronate—Shock—Prednisone—ankylosing spondylitis	8.18e-05	0.00114	CcSEcCtD
Pamidronate—Pain—Dexamethasone—ankylosing spondylitis	8.16e-05	0.00114	CcSEcCtD
Pamidronate—Pain—Betamethasone—ankylosing spondylitis	8.16e-05	0.00114	CcSEcCtD
Pamidronate—Nervous system disorder—Prednisone—ankylosing spondylitis	8.15e-05	0.00114	CcSEcCtD
Pamidronate—Tachycardia—Prednisone—ankylosing spondylitis	8.11e-05	0.00113	CcSEcCtD
Pamidronate—Hyperhidrosis—Prednisone—ankylosing spondylitis	8.03e-05	0.00112	CcSEcCtD
Pamidronate—Anorexia—Prednisone—ankylosing spondylitis	7.92e-05	0.00111	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	7.9e-05	0.0011	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—ankylosing spondylitis	7.87e-05	0.0011	CcSEcCtD
Pamidronate—Feeling abnormal—Betamethasone—ankylosing spondylitis	7.86e-05	0.0011	CcSEcCtD
Pamidronate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	7.86e-05	0.0011	CcSEcCtD
Pamidronate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	7.8e-05	0.00109	CcSEcCtD
Pamidronate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	7.8e-05	0.00109	CcSEcCtD
Pamidronate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	7.75e-05	0.00108	CcSEcCtD
Pamidronate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	7.73e-05	0.00108	CcSEcCtD
Pamidronate—Malaise—Methotrexate—ankylosing spondylitis	7.68e-05	0.00107	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—ankylosing spondylitis	7.62e-05	0.00107	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	7.57e-05	0.00106	CcSEcCtD
Pamidronate—Dizziness—Prednisolone—ankylosing spondylitis	7.56e-05	0.00106	CcSEcCtD
Pamidronate—Asthenia—Triamcinolone—ankylosing spondylitis	7.55e-05	0.00106	CcSEcCtD
Pamidronate—Body temperature increased—Betamethasone—ankylosing spondylitis	7.54e-05	0.00106	CcSEcCtD
Pamidronate—Body temperature increased—Dexamethasone—ankylosing spondylitis	7.54e-05	0.00106	CcSEcCtD
Pamidronate—Abdominal pain—Betamethasone—ankylosing spondylitis	7.54e-05	0.00106	CcSEcCtD
Pamidronate—Abdominal pain—Dexamethasone—ankylosing spondylitis	7.54e-05	0.00106	CcSEcCtD
Pamidronate—Asthenia—Methylprednisolone—ankylosing spondylitis	7.53e-05	0.00105	CcSEcCtD
Pamidronate—Insomnia—Prednisone—ankylosing spondylitis	7.52e-05	0.00105	CcSEcCtD
Pamidronate—Paraesthesia—Prednisone—ankylosing spondylitis	7.46e-05	0.00104	CcSEcCtD
Pamidronate—Pruritus—Triamcinolone—ankylosing spondylitis	7.44e-05	0.00104	CcSEcCtD
Pamidronate—Cough—Methotrexate—ankylosing spondylitis	7.43e-05	0.00104	CcSEcCtD
Pamidronate—Pruritus—Methylprednisolone—ankylosing spondylitis	7.43e-05	0.00104	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—ankylosing spondylitis	7.37e-05	0.00103	CcSEcCtD
Pamidronate—Dyspepsia—Prednisone—ankylosing spondylitis	7.32e-05	0.00102	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—ankylosing spondylitis	7.25e-05	0.00101	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—ankylosing spondylitis	7.25e-05	0.00101	CcSEcCtD
Pamidronate—Decreased appetite—Prednisone—ankylosing spondylitis	7.23e-05	0.00101	CcSEcCtD
Pamidronate—Rash—Prednisolone—ankylosing spondylitis	7.21e-05	0.00101	CcSEcCtD
Pamidronate—Dermatitis—Prednisolone—ankylosing spondylitis	7.21e-05	0.00101	CcSEcCtD
Pamidronate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	7.18e-05	0.001	CcSEcCtD
Pamidronate—Fatigue—Prednisone—ankylosing spondylitis	7.17e-05	0.001	CcSEcCtD
Pamidronate—Headache—Prednisolone—ankylosing spondylitis	7.17e-05	0.001	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—ankylosing spondylitis	7.16e-05	0.001	CcSEcCtD
Pamidronate—Constipation—Prednisone—ankylosing spondylitis	7.11e-05	0.000994	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—ankylosing spondylitis	7e-05	0.00098	CcSEcCtD
Pamidronate—Dizziness—Triamcinolone—ankylosing spondylitis	6.96e-05	0.000973	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—ankylosing spondylitis	6.95e-05	0.000972	CcSEcCtD
Pamidronate—Dizziness—Methylprednisolone—ankylosing spondylitis	6.94e-05	0.000971	CcSEcCtD
Pamidronate—Infection—Methotrexate—ankylosing spondylitis	6.9e-05	0.000965	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisone—ankylosing spondylitis	6.85e-05	0.000958	CcSEcCtD
Pamidronate—Asthenia—Betamethasone—ankylosing spondylitis	6.85e-05	0.000958	CcSEcCtD
Pamidronate—Asthenia—Dexamethasone—ankylosing spondylitis	6.85e-05	0.000958	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—ankylosing spondylitis	6.81e-05	0.000953	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	6.8e-05	0.000951	CcSEcCtD
Pamidronate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	6.8e-05	0.000951	CcSEcCtD
Pamidronate—Nausea—Prednisolone—ankylosing spondylitis	6.79e-05	0.00095	CcSEcCtD
Pamidronate—Pruritus—Dexamethasone—ankylosing spondylitis	6.75e-05	0.000945	CcSEcCtD
Pamidronate—Pruritus—Betamethasone—ankylosing spondylitis	6.75e-05	0.000945	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	6.72e-05	0.000939	CcSEcCtD
Pamidronate—Vomiting—Triamcinolone—ankylosing spondylitis	6.69e-05	0.000935	CcSEcCtD
Pamidronate—Vomiting—Methylprednisolone—ankylosing spondylitis	6.67e-05	0.000933	CcSEcCtD
Pamidronate—Rash—Triamcinolone—ankylosing spondylitis	6.63e-05	0.000928	CcSEcCtD
Pamidronate—Dermatitis—Triamcinolone—ankylosing spondylitis	6.63e-05	0.000927	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—ankylosing spondylitis	6.62e-05	0.000926	CcSEcCtD
Pamidronate—Rash—Methylprednisolone—ankylosing spondylitis	6.62e-05	0.000926	CcSEcCtD
Pamidronate—Dermatitis—Methylprednisolone—ankylosing spondylitis	6.61e-05	0.000925	CcSEcCtD
Pamidronate—Headache—Triamcinolone—ankylosing spondylitis	6.59e-05	0.000922	CcSEcCtD
Pamidronate—Headache—Methylprednisolone—ankylosing spondylitis	6.57e-05	0.00092	CcSEcCtD
Pamidronate—Abdominal pain—Prednisone—ankylosing spondylitis	6.57e-05	0.000919	CcSEcCtD
Pamidronate—Body temperature increased—Prednisone—ankylosing spondylitis	6.57e-05	0.000919	CcSEcCtD
Pamidronate—Diarrhoea—Dexamethasone—ankylosing spondylitis	6.53e-05	0.000913	CcSEcCtD
Pamidronate—Diarrhoea—Betamethasone—ankylosing spondylitis	6.53e-05	0.000913	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—ankylosing spondylitis	6.49e-05	0.000908	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	6.33e-05	0.000885	CcSEcCtD
Pamidronate—Dizziness—Betamethasone—ankylosing spondylitis	6.31e-05	0.000883	CcSEcCtD
Pamidronate—Dizziness—Dexamethasone—ankylosing spondylitis	6.31e-05	0.000883	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—ankylosing spondylitis	6.28e-05	0.000879	CcSEcCtD
Pamidronate—Nausea—Triamcinolone—ankylosing spondylitis	6.25e-05	0.000874	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—ankylosing spondylitis	6.24e-05	0.000872	CcSEcCtD
Pamidronate—Nausea—Methylprednisolone—ankylosing spondylitis	6.23e-05	0.000872	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—ankylosing spondylitis	6.19e-05	0.000866	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—ankylosing spondylitis	6.18e-05	0.000864	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisone—ankylosing spondylitis	6.12e-05	0.000857	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—ankylosing spondylitis	6.11e-05	0.000855	CcSEcCtD
Pamidronate—Vomiting—Dexamethasone—ankylosing spondylitis	6.07e-05	0.000849	CcSEcCtD
Pamidronate—Vomiting—Betamethasone—ankylosing spondylitis	6.07e-05	0.000849	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—ankylosing spondylitis	6.04e-05	0.000845	CcSEcCtD
Pamidronate—Rash—Betamethasone—ankylosing spondylitis	6.02e-05	0.000842	CcSEcCtD
Pamidronate—Rash—Dexamethasone—ankylosing spondylitis	6.02e-05	0.000842	CcSEcCtD
Pamidronate—Dermatitis—Dexamethasone—ankylosing spondylitis	6.01e-05	0.000841	CcSEcCtD
Pamidronate—Dermatitis—Betamethasone—ankylosing spondylitis	6.01e-05	0.000841	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	6e-05	0.000839	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—ankylosing spondylitis	5.99e-05	0.000838	CcSEcCtD
Pamidronate—Headache—Dexamethasone—ankylosing spondylitis	5.98e-05	0.000836	CcSEcCtD
Pamidronate—Headache—Betamethasone—ankylosing spondylitis	5.98e-05	0.000836	CcSEcCtD
Pamidronate—Asthenia—Prednisone—ankylosing spondylitis	5.96e-05	0.000834	CcSEcCtD
Pamidronate—Pain—Methotrexate—ankylosing spondylitis	5.94e-05	0.000831	CcSEcCtD
Pamidronate—Pruritus—Prednisone—ankylosing spondylitis	5.88e-05	0.000823	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—ankylosing spondylitis	5.72e-05	0.000801	CcSEcCtD
Pamidronate—Diarrhoea—Prednisone—ankylosing spondylitis	5.69e-05	0.000795	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	5.68e-05	0.000795	CcSEcCtD
Pamidronate—Nausea—Betamethasone—ankylosing spondylitis	5.67e-05	0.000793	CcSEcCtD
Pamidronate—Nausea—Dexamethasone—ankylosing spondylitis	5.67e-05	0.000793	CcSEcCtD
Pamidronate—Dizziness—Prednisone—ankylosing spondylitis	5.5e-05	0.000769	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—ankylosing spondylitis	5.49e-05	0.000768	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—ankylosing spondylitis	5.49e-05	0.000768	CcSEcCtD
Pamidronate—Vomiting—Prednisone—ankylosing spondylitis	5.28e-05	0.000739	CcSEcCtD
Pamidronate—Rash—Prednisone—ankylosing spondylitis	5.24e-05	0.000733	CcSEcCtD
Pamidronate—Dermatitis—Prednisone—ankylosing spondylitis	5.24e-05	0.000732	CcSEcCtD
Pamidronate—Headache—Prednisone—ankylosing spondylitis	5.21e-05	0.000728	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—ankylosing spondylitis	5.12e-05	0.000716	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—ankylosing spondylitis	4.98e-05	0.000697	CcSEcCtD
Pamidronate—Nausea—Prednisone—ankylosing spondylitis	4.94e-05	0.000691	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—ankylosing spondylitis	4.91e-05	0.000687	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—ankylosing spondylitis	4.75e-05	0.000665	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—ankylosing spondylitis	4.59e-05	0.000643	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—ankylosing spondylitis	4.42e-05	0.000618	CcSEcCtD
Pamidronate—Rash—Methotrexate—ankylosing spondylitis	4.38e-05	0.000613	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—ankylosing spondylitis	4.38e-05	0.000612	CcSEcCtD
Pamidronate—Headache—Methotrexate—ankylosing spondylitis	4.35e-05	0.000609	CcSEcCtD
Pamidronate—Nausea—Methotrexate—ankylosing spondylitis	4.13e-05	0.000577	CcSEcCtD
